Newsroom

Frost & Sullivan Applauds IRIS for Innovation in Diabetic Retinopathy Technology 3.3.16

By broadening exam access via seamless cloud-based technology, IRIS is enabling more physicians to identify patients at risk of blindness MOUNTAIN VIEW, Calif., Feb. 2, 2016 /PRNewswire/ -- Based on its recent analysis of the diabetic retinopathy market, Frost & Sullivan recognizes US-based...

Share

Facebook icon
Twitter icon
LinkedIn icon
Pinterest icon
e-mail icon